| CIRD75050 | Introduction |
| CIRD75100 | Requirement that a
company is a going concern |
| CIRD75200 | Qualifying expenditure:
for an accounting period |
| CIRD75300 | Qualifying expenditure:
on direct R&D |
| CIRD75400 | Qualifying expenditure:
on sub-contracted R&D |
| CIRD75500 | Qualifying expenditure:
on contributions to independent R&D |
| CIRD75525 | Subcontracting to
charities, universities and scientific research organisations |
| CIRD75550 | Subcontracting to
companies and others |
| CIRD75600 | How relief is given:
SMEs |
| CIRD75700 | How relief is given:
large companies |
| CIRD75800 | How relief is given:
insurance companies |
| CIRD75900 | Inflated claims |
| CIRD75950 | Refunds of contributions
and subcontract payments |
| CIRD76000 | Specified diseases:
general |
| CIRD76100 | Specified diseases:
tuberculosis and malaria |
| CIRD76200 | Specified diseases:
HIV/AIDS |
| CIRD76300 | Definitions |
| CIRD76400 | Dealing with claims |
